Mike Tansey MD

Michael has extensive international experience in all phases of drug development across a wide range of therapeutic areas and in all major markets, including Japan.

He has considerable expertise in strategic and hands-on operational project management, with involvement in over 40 regulatory submissions worldwide. Involved in launch and market support activities both centrally and in market companies.

In addition Michael has extensive experience in US, European and Asian regulatory strategy, with successful filings in all these regions. He has led successful process optimization in two major companies.

He has held positions in Hoechst, Glaxo, Rhone-Poulenc Rorer, and latterly Pharmacia until the Pfizer acquisition in 2003. In Pharmacia he was CMO & SVP Medical Development with 1500 staff in 52 countries and member of Chief Executive’s Operations Committee.

Since 2003 Michael has worked with more than 14 biotech companies and CROs in the USA and Europe. Activities have included fund-raising, in- and out-licensing, partnering, strategic and operational oversight and process improvement.